A qualifying BMI or related health condition is typically required GLP-1 medications like semaglutide are usually prescribed to adults with a BMI over 30, or over 27 if they have a weight-related condition, such as high blood pressure, prediabetes, sleep apnea, or PCOS
Briefly, the SEMPA trial (Effect of Empagliflozin and Semaglutide on Cardio-Renal Target Organ Damage in Patients with Type 2 Diabetes A Randomized Trial
Reduced appetite becomes noticeable within days after starting treatment
Both types of PE-AA oxidation, enzymatic (by lipoxygenase) and non-enzymatic (by autooxidation to PE-AA-OOH), eventually result in cell death [18, 30,31,32]
Which one should you focus on, though